Press release content from News Direct Corporation. The AP news staff was not involved in its creation.
hVIVO contract the fruit of increasing Asian focus
PRESS RELEASE: Paid content from News Direct Corporation
Press release content from News Direct Corporation. The AP news staff was not involved in its creation.January 4, 2023 GMT
hVIVO PLC (AIM:HVO) chief executive Mo Khan speaks to Proactive after announcing the signing of a £5.2mln contract with a biotech company in the Asia Pacific region to test the latter’s respiratory syncytial virus (RSV) vaccine candidate. Khan says that the deal is the first hVIVO has signed in Asia in a decade, and is the result of the research company’s increasing focus on growing its sales in the region
Proactive UK Ltd
+44 20 7989 0813
View original content to download multimedia: https://newsdirect.com/news/hvivo-contract-the-fruit-of-increasing-asian-focus-358578173